Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Res. 2005 Apr 15; 65(8):3454-61.